NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1356508501 MD
Verify on CMS → Irfan Jawed, MD
Medical Oncology Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 188 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · Penalty band
Industry payments
$1.1K
47 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Irfan Jawed, MD reported a CMS MIPS final score of 0/100 - below the 83.1 national average - and filed 1,635 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 2K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Irfan Jawed, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Irfan Jawed, MD sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Irfan Jawed, MD writes more Part D claims than 88% of them and scores higher on MIPS quality than 0% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Irfan Jawed, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Irfan Jawed, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Irfan Jawed, MD?
Below national averagePrimary specialty
Medical Oncology Physician
Medicare Part D claims
1,635 137% vs specialty avg
MIPS final score
0/100 83.1 pts vs avg
Specialty distribution in Texas
How Medical Oncology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Irfan Jawed, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 0/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Irfan Jawed, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 13310 BEAMER RD STE B, Houston, TX, 77089, with a listed phone of (832) 879-2942. NPI 1356508501 was issued on 05/16/2008.
Medicare Part D records for calendar year 2023 show 1,635 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 48.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356508501 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/16/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
0
Final Score
Avg: 83.1
0
Quality
Reporting: Individual
Hospital and facility affiliations
Facilities where Irfan Jawed, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Irfan Jawed MD PLLC
Houston, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Irfan Jawed, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.1K
Largest payer
SOBI, INC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Irfan Jawed, MD. To verify Irfan Jawed, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Irfan Jawed, MD - brand share 12.0%
Medical Oncology Physician average
12% brand-name claims vs 88% generic, on 1,635 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,635
Total Claims
$1.3M
Total Drug Cost
188
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,725
- Total Day Supply
- 31,481
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $79K
- Opioid Claims
- 794 (48.6% rate)
Patient Demographics
- Average Patient Age
- 67.5 years
- Avg HCC Risk Score
- 3.51
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 53, 65-74: 88, 75-84: 35, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Irfan Jawed, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
473 claims
- Gabapentin 113
Gabapentin
113 claims
- Oxycodone Hcl 95
Oxycodone Hcl
95 claims
- Oxycodone-Acetamin… 93
Oxycodone-Acetaminophen
93 claims
- Tizanidine Hcl 88
Tizanidine Hcl
88 claims
- Eliquis 64
Eliquis
64 claims
- Cyclobenzaprine Hcl 49
Cyclobenzaprine Hcl
49 claims
- Morphine Sulfate Er 48
Morphine Sulfate Er
48 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 473 |
| Gabapentin | 113 |
| Oxycodone Hcl | 95 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 93 |
| Tizanidine Hcl | 88 |
| Eliquis Apixaban | 64 |
| Cyclobenzaprine Hcl | 49 |
| Morphine Sulfate Er Morphine Sulfate | 48 |
| Granisetron Hcl Granisetron Hcl/Pf | 40 |
| Pregabalin | 39 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Irfan Jawed, MD fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Irfan Jawed, MD's 1,635 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Jawed.
Dr. Chinemerem Abanonu
MD
Katy, TX
Dr. James Abbruzzese
M.D.
Houston, TX
Dr. Seyed Abedi
M.D.,PH.D.
Cedar Park, TX
Dr. Sausan Abouharb
M.D
Houston, TX
Dr. Fadi Abu-Shahin
MD
Houston, TX
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Irfan Jawed, MD's specialty? ▼
Irfan Jawed, MD specializes in Medical Oncology Physician and practices in Houston, Texas. Credentials: MD.
How much does Irfan Jawed, MD prescribe under Medicare Part D? ▼
In 2023, Irfan Jawed, MD wrote 1,635 Medicare Part D claims totaling $1.3M in drug costs for 188 beneficiaries.
What is Irfan Jawed, MD's Medicare quality score? ▼
Irfan Jawed, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Irfan Jawed, MD located? ▼
Irfan Jawed, MD is located at 13310 BEAMER RD STE B, Houston, TX, 77089. Phone: (832) 879-2942.
What is Irfan Jawed, MD's NPI number? ▼
Irfan Jawed, MD's National Provider Identifier (NPI) is 1356508501, issued on 05/16/2008.
Does Irfan Jawed, MD prescribe more brand-name or generic drugs? ▼
Irfan Jawed, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $1.3M in brand drug costs.
Does Irfan Jawed, MD prescribe opioids? ▼
Yes, Irfan Jawed, MD had 794 opioid claims in 2023 with an opioid prescribing rate of 48.6%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Irfan Jawed, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Irfan Jawed, MD's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Gabapentin, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Irfan Jawed, MD accept Medicare? ▼
Irfan Jawed, MD appears in CMS Medicare data with 1,635 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Irfan Jawed, MD's credentials? ▼
Irfan Jawed, MD's NPI is 1356508501 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.